Chemotherapy Dose Intensity Determination as a Quality of Care Measure for Managed Care Organizations in the Treatment of Early-Stage Breast Cancer
Author:
Affiliation:
1. Southeast Region, One Health Plan, Atlanta, Ga,
2. Aetna US Healthcare, Woodland Hills, Calif
3. Nephrology Professional Services, Amgen Inc, Thousand Oaks, Calif
4. Pharmacoeconomics, Amgen Inc, Thousand Oaks, Calif
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Health Policy
Link
http://journals.sagepub.com/doi/pdf/10.1177/106286060201700604
Reference14 articles.
1. Cancer statistics, 2000
2. Breast Cancer Survival and Treatment in Health Maintenance Organization and Fee-for-Service Settings
3. Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care
4. Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles.
5. Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Racial Differences in Breast Cancer Therapeutic Toxicity: Implications for Practice;Cancer Epidemiology, Biomarkers & Prevention;2023-02-06
2. Budget impact analysis of trilaciclib for decreasing the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small cell lung cancer in the United States;Journal of Managed Care & Specialty Pharmacy;2022-04
3. Pegylated Liposomal Doxorubicin (Caelyx®) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial;Current Oncology;2021-12-07
4. Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy;Breast Cancer Research and Treatment;2015-05-09
5. Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus;Cancer Chemotherapy and Pharmacology;2015-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3